Hematopoietic cell transplantation (HCT) recipients are at increased risk of developing primary and recurrent
No takes yet. Share an insight, caveat, or question.
Deshpande et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: